All Industries

Top Therapeutics Companies

765 Therapeutics companies, sorted by total funding raised.

ARS PharmaceuticalsIPO

Develops and commercializes neffy, an FDA-approved needle-free epinephrine nasal spray for treati...

San Diego, United States51–200Healthcare, Therapeutics
Series DTotal funding$75.0MAug 2021
Georgiamune

Clinical-stage biotech building a pipeline of immunomodulators that enhance or inhibit immune sig...

Gaithersburg, United States11–50Life Sciences, Biotech
Series ATotal funding$75.0MAug 2023
Precision BioSciencesIPO

Clinical-stage gene editing company developing in vivo therapies using its proprietary ARCUS geno...

Durham, United States51–200Biotech, Genomics
Venture RoundTotal funding$75.0MJun 2022
Spark TherapeuticsAcquired

Spark Therapeutics develops gene therapy treatments for debilitating genetic diseases; acquired b...

Philadelphia, United States201–500Biotech, Therapeutics
Series BTotal funding$72.8MMay 2014
Hydra Biosciences, Inc.Closed

Private biopharmaceuticals company pioneering the discovery of novel drugs using its expertise in...

Cambridge, United States11–50Biotech, Drug Discovery
Series ETotal funding$72.2MMar 2015
Delphia Therapeutics

Delphia is pioneering an entirely new field of cancer biology called activation lethality to adva...

Cambridge, United States11–50Biotech, Therapeutics
Series ATotal funding$67.0MMay 2024
Hillstar Bio

Developing novel precision immunotherapies to revolutionize autoimmune disease treatment

Biotech, Healthcare
Series ATotal funding$67.0MMar 2025
Shasqi

Biotech company using click chemistry to selectively activate cancer drugs at the tumor site, imp...

San Francisco, United States11–50Biotech, Healthcare
GrantTotal funding$65.5MAug 2024
VintaBio
Biotech, Drug Discovery
Series CTotal funding$64.0MApr 2023
Vivatides Therapeutics

Biotech developing extrahepatic siRNA and ASO delivery platforms for RNA therapeutics beyond the ...

Suzhou, ChinaBiotech, Therapeutics
Series ATotal funding$64.0MApr 2026
Bionaut Labs

Develops microscale wireless micro-robots to deliver therapies and diagnostics to deep body locat...

Los Angeles, United States11–50Biotech, Medical Devices
Extension RoundTotal funding$63.2MFeb 2024
Lighthouse Pharmaceuticals

Alzheimer's disease therapeutics

Novato, United StatesBiotech, Therapeutics
Series ATotal funding$61.2MApr 2026
Elevian

Health & Life Sciences company

United States11–50Biotech, Healthcare
Series ATotal funding$60.5MSep 2021
64x Bio

High throughput design of cells for therapeutics applications.

Brisbane, United States11–50Artificial Intelligence, Healthcare
Series ATotal funding$60.0MJan 2022
89bio

Biopharmaceutical company focused on nonalcoholic steatohepatitis (NASH) and other liver and meta...

San Francisco, United StatesBiotech, Healthcare
Series ATotal funding$60.0MOct 2018
Excision

Gene editing therapeutics company

San Francisco, United States11–50Biotech, Genomics
GrantTotal funding$60.0MSep 2022
Surge Therapeutics

Develops an injectable intraoperative immunotherapy hydrogel to prevent post-surgical cancer recu...

Cambridge, United States1–10Biotech, Drug Discovery
Series BTotal funding$58.0MJul 2023
Kimia Therapeutics
Biotech, Therapeutics
Series ATotal funding$55.0MDec 2023
Appia BioClosed

Develops allogeneic CAR‑iNKT cell therapies from hematopoietic stem cells to treat cancers, partn...

Los Angeles, United States11–50Biotech, Drug Discovery
Series ATotal funding$52.0MMay 2021
Deep Apple Therapeutics
Biotech, Therapeutics
Series ATotal funding$52.0MDec 2023
EndologixAcquired
Biotech, Healthcare
Venture RoundTotal funding$52.0MMar 2019
PB
Pardes BiosciencesAcquired

We break viruses

Carlsbad1–10Biotech, Healthcare
Series ATotal funding$51.6MJan 2021
VivusAcquired

Company developing pharmaceutical therapeutics

Mountain View, United States11–50Healthcare, Therapeutics
Corporate RoundTotal funding$51.1MNov 2006
GLYTR THERAPEUTICS, INC.

R&D company with 5 SBIR/STTR awards from Department of Health and Human Services.

Irvine, United States1–10Biotech, Diagnostics
GrantTotal funding$50.4MSep 2025
Belharra Therapeutics
Advanced Materials, Biotech
Series ATotal funding$50.0MJan 2023